Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD

Catherine Le Berre, Laurent Peyrin-Biroulet, SPIRIT-IOIBD study group, Pia Susanne Munkholm (Medlem af forfattergruppering)

92 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology